Composition
- Active ingredients
- APIXABAN 5MG
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- APIXABAN 2.5MG · TabletANDA209810-001 · Discontinued
- APIXABAN 5MG · TabletANDA209810-002 · Discontinued
- APIXABAN 2.5MG · TabletANDA210026-001 · Discontinued
- APIXABAN 5MG · TabletANDA210026-002 · Discontinued
- APIXABAN 5mg · TabletANDA210133-002 · Tentative approval
- APIXABAN 2.5MG · TabletANDA210156-001 · Discontinued
- APIXABAN 5MG · TabletANDA210156-002 · Discontinued
- APIXABAN 5MG · TabletANDA209845-002 · Discontinued
- APIXABAN 2.5MG · TabletANDA209845-001 · Discontinued
- APIXABAN 2.5MG · TabletANDA210067-001 · Discontinued
- APIXABAN 5MG · TabletANDA210067-002 · Discontinued
- APIXABAN 2.5MG · TabletANDA210082-001 · Tentative approval
- APIXABAN 2.5MG · TabletANDA218119-002 · Tentative approval
- APIXABAN 2.5MG · TabletANDA218519-005 · Tentative approval
- APIXABAN 2.0MG · Tablet
At a glance
- Brand name
- Apixaban
- Route
- Oral
- Dosage form
- Tablet
- Applicant
- Hetero Labs LTD V
- Status
- Discontinued
- FDA approval
- 21 Nov 2023
- Application
- ANDA210066-002